Neuro Enhancement 

Description

The Neuro Enhancement Research Kit combines Selank (10mg) and Semax (10mg) — two synthetic neuropeptides developed by the Institute of Molecular Genetics (Russian Academy of Sciences) that modulate complementary neurological pathways: GABAergic/anxiolytic regulation (Selank) and BDNF-mediated cognitive and neuroprotective signaling (Semax).

Kit Components

• Selank (10mg): Modified tuftsin heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) that modulates GABA-A receptor function, increases hippocampal GABA levels, upregulates BDNF, and influences IL-6 and IFN-γ expression. Studied for anxiolytic effects without GABA receptor direct agonism or tolerance induction in rodent models.
• Semax (10mg): ACTH(4-10) analogue (Met-Glu-His-Phe-Pro-Gly-Pro) that stimulates BDNF expression in the hippocampus and prefrontal cortex, modulates dopaminergic and serotonergic systems, and has been studied for neuroprotection in ischemia models.

Research Context

Both peptides upregulate BDNF through different mechanisms — Selank via GABAergic modulation and immune pathway interaction, Semax via direct ACTH fragment bioactivity. This shared BDNF endpoint via divergent pathways provides a natural pairing for researchers studying BDNF regulation, synaptic plasticity, and cognitive function through multiple upstream mechanisms simultaneously.

Common Research Applications

• BDNF upregulation through complementary pathway studies
• GABAergic + dopaminergic/serotonergic interaction research
• Anxiety, stress resilience, and fear extinction models
• Neuroprotection and cognitive function pathway investigation

For Research Use Only. Not for human or veterinary use.